SANOFI purchased 38.3% of their position (300K shares) of ATTOVIA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.10M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/7/2026ACC: 0001193125-26-340173
+300K
Net shares
Net buyer
$5.10M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
1.08M acquired · 782.86K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+782.86K
Price / share
—
Trade value
—
% of position
New position
8/6/2026
0.00→782.86K
Common Stock
Indirect
Shares
+300K
Price / share
$17.00
Trade value
$5.10M
% of position
38.3%
8/6/2026
782.86K→1.08M
Total
Net shares
+1.08M
Net value
$5.10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/6/2026 | C · Conversion | +782.86K | — | — | New position | 0.00 | 782.86K |
| Common Stock Indirect | 8/6/2026 | P · Purchase | +300K | $17.00 | $5.10M | 38.3% | 782.86K | 1.08M |
| Total | +1.08M | $5.10M | ||||||
Derivative Transactions1
Series C Preferred Stock
Indirect
Converts to
Common Stock
782.86K shares
Shares
−782.86K
Strike price
Held after
0.00
Exercisable
—
8/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Preferred Stock Indirect | Common Stock782.86K shares | 8/6/2026 | C · Conversion | −782.86K | — | 0.00 |